Best Cedar Rapids Grants for Nonprofits in Iowa

The Ethel Strickarz Memorial Scholarship aims to address community needs through educational support in special education and related fields. Funded by the Community Foundation of Elmira-Corning and the Finger Lakes, it encourages students pursuing careers in human services, nursing, psychology, speech pathology, or therapy. This scholarship reflects a commitment to holistic community development by fostering future professionals dedicated to improving lives and addressing urgent societal challenges.

The Dean and Janice Butts Scholarship aims to support students pursuing post-secondary education, vocational training, or college, with a preference for students of color. This initiative is part of a broader commitment by the Community Foundation of Elmira-Corning and the Finger Lakes, Inc. to address various community needs, including education and wellness, while fostering awareness and creative solutions to future challenges.

The SHAPE America Major of the Year Award recognizes exemplary undergraduate students in health, physical education, recreation, and dance. This prestigious accolade aims to highlight nominees who demonstrate academic excellence and commitment to service within their communities. Faculty members from colleges and universities are encouraged to nominate one outstanding student per major, ensuring that the next generation of health educators is celebrated for their achievements and contributions to the field.

The SHAPE America: Joy of Effort Award recognizes dedicated individuals who exemplify the spirit of commitment and passion in health and physical education. Awardees are current SHAPE America members with at least three years of membership, demonstrating excellence in teaching, coaching, or leadership. This prestigious award celebrates those who have made significant contributions to the field, inspiring others to lead healthy, active lives through their efforts in education and advocacy.

The Sherry Wagner-Henry Board Fellowship, initiated by the United States Institute for Theatre Technology (USITT), offers a unique opportunity for emerging leaders in the theatre and entertainment industry. This 12-18 month program connects Fellows with experienced board members to enhance their professional skills. Participants gain access to board resources, attend meetings, and receive support for conferences, all valued at approximately $3,000 to $3,500. Ideal for individuals with 2-5 years of experience, this Fellowship fosters growth and leadership in nonprofit governance.

The BACKstage Grant Fall 2025, offered by the United States Institute for Theatre Technology (USITT), provides funding for secondary education theatre teachers to enhance their professional development. Grants support various expenses, including workshop registrations, travel, and educational supplies. Eligible applicants must be secondary school educators teaching theatre-related subjects, and all funded activities must be completed within a year. This initiative fosters growth and innovation in the performing arts community.

The David A. Evans Award for the Advancement and Education of Organic Synthesis, presented by the American Chemical Society, recognizes exceptional achievements in organic synthesis research and education. Established in 2023, this award includes a $5,000 prize and reimbursement for travel expenses up to $2,500 for the award ceremony. It promotes inclusivity, granting opportunities irrespective of race, gender, or background, fostering a diverse scientific community committed to advancing chemistry.

The ACS - Fanconi Cancer Foundation Discovery Boost Grant invites innovative proposals for translational cancer research addressing the challenges faced by individuals with Fanconi anemia (FA). This grant supports high-risk, high-reward projects aimed at improving detection, prevention, or treatment of FA-related cancers. With funding of up to $135,000 per year for two years, it encourages research in early detection technologies, prevention mechanisms, and therapeutic strategies tailored to the unique sensitivities of the FA population.

The Metabolic Dysfunction-Associated Steatohepatitis Fund, established by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients facing chronic illnesses. It provides critical support for expenses related to prescription copays, insurance premiums, and transportation for treatment. With a maximum award of $8,000, the fund ensures that individuals can access necessary healthcare services without financial strain. This initiative emphasizes the commitment to improving health outcomes for those affected by metabolic dysfunction-associated steatohepatitis.

The Mantle Cell Lymphoma Fund, managed by the HealthWell Foundation, provides financial assistance to underinsured patients diagnosed with Mantle Cell Lymphoma. The fund covers prescription drug copays and Medicare Part B premiums, with a maximum award of $8,500. Eligible patients must have insurance that covers their medication and meet specific income guidelines. The foundation aims to reduce financial barriers to essential treatments, ensuring that patients receive necessary care without undue financial strain.

The HealthWell Foundation's Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements Fund provides essential financial assistance for individuals facing significant health challenges. By covering copays, deductibles, and related expenses, the fund aims to alleviate the financial burden on underinsured patients. With a commitment to enhancing healthcare access, the Foundation has awarded over $1.2 billion since its inception, ensuring that vital treatments remain accessible to those in need.

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

The Emergency/Medical Workers Behavioral Health Fund aims to support emergency workers facing trauma and anxiety due to their roles. Established by the HealthWell Foundation, it provides financial assistance for treatment-related costs, including copayments for prescription drugs, counseling, and transportation. In 2024, the Foundation awarded over $1.2 billion to underinsured patients, ensuring no one is denied essential healthcare due to financial barriers. This initiative helps address the critical mental health needs of those who serve on the front lines.

The Dupuytren’s Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from Dupuytren's Disease. This fund provides assistance for prescription drug copays and insurance premiums related to treatment. With an average grant utilization of $1,650 over a 12-month period, the fund ensures that essential medications and therapies are affordable. HealthWell Foundation, a private non-profit, has helped over 1.1 million patients since 2004, demonstrating its commitment to healthcare access.

The Cushing's Disease or Cushing's Syndrome Fund, operated by the HealthWell Foundation, provides vital financial assistance to underinsured patients facing high medical costs associated with these conditions. The fund covers co-payments, insurance premiums, and necessary treatments, ensuring that patients receive the care they need without financial burden. With an average grant utilization of $3,000 over twelve months, this fund aims to alleviate the challenges of treatment accessibility, supporting both physical and mental health for those affected.

The Congenital Sucrase-Isomaltase Deficiency Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from this genetic disorder. By providing assistance with prescription drugs and treatment costs, the fund ensures that vital medications are accessible, allowing patients to manage their condition effectively. In 2024, the Foundation is expected to award over $1.2 billion in grants, showcasing its commitment to enhancing healthcare access for those in need.

The Chronic Lymphocytic Leukemia Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients battling chronic lymphocytic leukemia (CLL). This fund provides essential support for prescription copays and premiums, ensuring that patients can access necessary treatments without the stress of financial constraints. Since its inception, the foundation has awarded over $1.2 billion in grants, helping more than 1.1 million patients. The initiative emphasizes the importance of accessible healthcare and aims to improve the quality of life for those affected by this condition.

The Cancer-Related Behavioral Health Fund, established by the HealthWell Foundation, provides financial assistance to individuals diagnosed with cancer for behavioral health treatments. This fund covers costs associated with prescription drugs, counseling services, and transportation. Aiming to alleviate financial burdens, it ensures that underinsured patients can access necessary care without delay. In 2024, the foundation awarded over $1.2 billion, emphasizing its commitment to improving health outcomes for cancer patients across the United States.

The Blepharitis Fund, managed by the HealthWell Foundation, aims to alleviate financial barriers for underinsured patients suffering from blepharitis, an inflammatory condition of the eyelids. This program assists with prescription drug copays and insurance premiums, covering up to $3,500 annually for treatments. With a mission to ensure no patient is deprived of necessary healthcare due to financial constraints, the HealthWell Foundation has provided over $1.2 billion in grants, supporting more than 1.1 million patients since its inception.

The ANCA-Assoc Vasculitis and Granulomatosis with Polyangiitis Fund, established by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from this rare and serious condition. The fund assists with copays, premiums, and out-of-pocket expenses related to treatment, ensuring that affected individuals have access to necessary medications. With over $1.2 billion in grants awarded since 2004, the foundation has helped over 1.1 million patients access critical healthcare services.

The Amyotrophic Lateral Sclerosis Fund, managed by HealthWell Foundation, aims to alleviate financial barriers for underinsured patients battling ALS, a progressive neurodegenerative disease. The fund provides financial assistance for prescription copays, insurance premiums, and related healthcare expenses, ensuring patients can access vital treatments. With an average grant utilization of $3,000 over twelve months, the fund exemplifies HealthWell's commitment to ensuring no patient is denied necessary healthcare due to cost. Since 2004, HealthWell has awarded over $1.2 billion in grants, supporting more than 1.1 million patients.

The Amyloidosis Fund, managed by the HealthWell Foundation, provides essential financial assistance to underinsured patients facing treatment costs for Amyloidosis. The program covers prescription copays, insurance premiums, and related expenses, ensuring that patients can access necessary medications without financial strain. With a maximum award of $8,000, the fund aims to alleviate the burden of healthcare costs for those diagnosed with this complex disease, promoting better health outcomes and quality of life for patients across the United States.

The Alagille Syndrome Vitamins and Supplements Fund, managed by the HealthWell Foundation, offers financial assistance to patients suffering from Alagille Syndrome. This fund helps cover the costs of essential vitamins and supplements needed for treatment. With a maximum award of $1,500, the program aims to reduce financial barriers for underinsured individuals, ensuring they receive the necessary support to manage their health, thereby enhancing their quality of life.

The Philip J. Wyatt Award in Analytical Chemistry, established in 1947 and endowed by the Wyatt Family Foundation in 2026, recognizes outstanding contributions to analytical chemistry. Offered by the American Chemical Society, the award includes a $5,000 prize and a certificate, with up to $2,500 for travel expenses to the award presentation meeting. This award supports diversity and inclusion by being available regardless of race, gender, or background, promoting a global community in the field of chemistry.

The Guitar Center Music Foundation is an independent 501c3 organization. Through instrument grants and donations, we help ensure schools and music education programs get the resources they need to keep music alive and accessible. We believe in a world in which music is cherished and respected for the immense value it brings to humanity, where every person who seeks to pursue music has the means to do so.

Our mission is to give everyone the power to create and express themselves through music. Since 2005, we have supported hundreds of music education and therapy programs and reached over 300,000 people. With your generous support, we aim to assist many more.

Guitar Center Music Foundation Grants

The Guitar Center Music Foundation awards musical instruments and equipment in-kind to public schools and music programs in need. 

Instrument grants range from up to $1,000 to $5,000 based upon need.

This funding opportunity aims to enhance the development of medical products in rare diseases through innovative natural history studies. By generating high-quality data, the FDA seeks to bridge critical knowledge gaps and eliminate barriers in rare disease research. The initiative focuses on diseases with unmet needs, fostering significant impacts for those affected and facilitating the development of effective therapeutic solutions.

The Helen M. Heitmann Young Scholar Award, presented by SHAPE America, honors young professionals who have made significant contributions to research in curriculum and instruction within health and physical education. Eligible candidates must be current SHAPE America members and have 3 to 6 years of experience post-doctorate. This award emphasizes active involvement and scholarship in the field, encouraging innovative research that enhances educational practices for preK-12 students.